Home/Pipeline/Allergy Vaccine

Allergy Vaccine

Allergy

Clinical TrialActive

Key Facts

Indication

Allergy

Phase

Clinical Trial

Status

Active

Company

FunPep

About FunPep

Japanese biotech developing functional peptides for skin ulcers and antibody-inducing vaccines, with a Phase III candidate showing angiogenesis and antimicrobial activity.

View full company profile

Therapeutic Areas

Dermatology Immunology Infectious Disease

Other Allergy Drugs

Drug	Company	Phase	Status
Human Allergy	Genclis	Preclinical	Active
CAL-4	Calyxha Biotechnologies	Discovery	Active